Terms: = Liver cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Staging
4 results:
1. The cross-talk between DDR1 and stat3 promotes the development of hepatocellular carcinoma.
Lin Y; Jin H; Wu X; Jian Z; Zou X; Huang J; Guan R; Wei X
Aging (Albany NY); 2020 Jul; 12(14):14391-14405. PubMed ID: 32716315
[TBL] [Abstract] [Full Text] [Related]
2. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma.
Xu QG; Yuan SX; Tao QF; Yu J; Cai J; Yang Y; Guo XG; Lin KY; Ma JZ; Dai DS; Wang ZG; Gu FM; Zhao LH; Li LQ; Liu JF; Sun SH; Zang YJ; Liu H; Yang F; Zhou WP
J Hepatol; 2019 May; 70(5):904-917. PubMed ID: 30654066
[TBL] [Abstract] [Full Text] [Related]
3. IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/stat3 signaling.
Pu XY; Zheng DF; Shen A; Gu HT; Wei XF; Mou T; Zhang JB; Liu R
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):408-415. PubMed ID: 30201411
[TBL] [Abstract] [Full Text] [Related]
4. IL-17 Producing Cells and RORγt mRNA Transcriptional Factor in Cirrhotic and HCC Egyptian Patients.
El Bassuoni MA; Soliman MA; El Megeed NA; Al Gazar A
Egypt J Immunol; 2015; 22(1):59-68. PubMed ID: 26415373
[TBL] [Abstract] [Full Text] [Related]
